Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: long-term outcomes of a phase I–II trial
oleh: Cui Di, Du Lei, Yu Wei, Cai Boning, Meng Lingling, Yang Jun, Luo Yanrong, Chen Jing, Ma Lin
| Format: | Article |
|---|---|
| Diterbitkan: | Sciendo 2022-03-01 |
Deskripsi
Our previous study showed that two different regimens of moderate hypofractionated radiotherapy (HFRT) delivered with helical tomotherapy (HT) are well tolerated in older prostate cancer patients. We provide a longterm efficacy and toxicity after > 7 years of follow-up.